Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01296152
What this trial is testing

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 25
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Not applicableStudy completedNCT00413153
What this trial is testing

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Who this might be right for
HIV Infections
Massachusetts General Hospital 15
Large-scale testing (Phase 3)Study completedNCT00262522
What this trial is testing

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Who this might be right for
Human Immunodeficiency Virus Infections
Abbott 664
Post-approval studies (Phase 4)Study completedNCT00145795
What this trial is testing

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Who this might be right for
HIV Infections
University of Chicago 20
Large-scale testing (Phase 3)Ended earlyNCT00443703
What this trial is testing

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 352
Post-approval studies (Phase 4)Ended earlyNCT00679926
What this trial is testing

Kaletra and Viread in Antiretroviral Naïve Patients

Who this might be right for
HIV Infections
Oklahoma State University Center for Health Sciences 6
Testing effectiveness (Phase 2)WithdrawnNCT00121017
What this trial is testing

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Who this might be right for
HIV InfectionHepatitis C
Abbott 200
Testing effectiveness (Phase 2)Ended earlyNCT04307693
What this trial is testing

Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Asan Medical Center 65
Large-scale testing (Phase 3)Study completedNCT01237444
What this trial is testing

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Who this might be right for
HIV Infection
Pedro Cahn 417
Early research (Phase 1)Study completedNCT02159352
What this trial is testing

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 49
Post-approval studies (Phase 4)Ended earlyNCT00775606
What this trial is testing

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Who this might be right for
Acquired Immune Deficiency Syndrome
Rush University Medical Center 15
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Study completedNCT00946595
What this trial is testing

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 420
Not applicableUnknownNCT00578825
What this trial is testing

A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome

Who this might be right for
Severe Acute Respiratory Syndrome
Hospital Authority, Hong Kong 340
Testing effectiveness (Phase 2)Study completedNCT00038220
What this trial is testing

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Who this might be right for
HIV Infections
Abbott 40
Large-scale testing (Phase 3)Study completedNCT00978068
What this trial is testing

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Who this might be right for
MalariaHIV Infections
University of California, San Francisco 176
Early research (Phase 1)Study completedNCT00985543
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Who this might be right for
Acquired Immunodeficiency Syndrome
Kirby Institute 22
Testing effectiveness (Phase 2)Study completedNCT00043953
What this trial is testing

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Who this might be right for
HIV Infections
Abbott 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation